Alkem Laboratories Limited (NSE:ALKEM)
India · Delayed Price · Currency is INR 5,368.00
-81.50 (-1.50%)
Aug 14, 2026, 3:15 PM IST
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 641.82 billion as of August 14, 2026. Its market cap has decreased by -0.38% in one year.
Market Cap
641.82B
Enterprise Value
626.97B
Revenue
150.81B
Ranking
n/a
PE Ratio
29.75
Stock Price
5,368.00
ChartMarket Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 641.82B, an increase of 288.51%. That is a compound annual growth rate of 13.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 641.82B | -2.52% |
| Dec 31, 2025 | 658.38B | -2.26% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cipla | 1.18T |
| Zydus Lifesciences | 1.16T |
| Laurus Labs | 999.65B |
| Mankind Pharma | 993.01B |
| Aurobindo Pharma | 957.08B |
| Glenmark Pharmaceuticals | 654.71B |
| Gland Pharma | 489.53B |
| Ipca Laboratories | 455.73B |